«Vascular Endothelial Growth Factor Receptor-1

Below is an extended Vascular Endothelial Growth Factor Receptor-1 patents listing. Click here to return to the Vascular Endothelial Growth Factor Receptor-1 main in depth entry.

Patents :
US Patent No.	Title
7407659	Methods of diagnosing pre-eclampsia or eclampsia
6986890	Anti-human VEGF receptor Flt-1 monoclonal antibody
6855508	ELISA for VEGF
6846839	Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis
6831075	Heterocyclic substituted pyrazolones
6800760	Quinolinone derivatives
6774237	Quinolinone derivatives
6762194	Quinolinone derivatives
6759417	Heterocyclic compounds
6756383	Heterocyclic derivatives of quinolinone benimidazoles
6734017	Antisense modulation of vascular endothelial growth factor receptor-2 expression
6726718	Medical articles prepared for cell adhesion
6710174	Antisense inhibition of vascular endothelial growth factor receptor-1 expression
6617160	Anti-human VEGF receptor Flt-1 monoclonal antibody
6610484	Identifying material from a breast duct
6605617	Quinolinone derivatives
6455525	Heterocyclic substituted pyrazolones
7052693	Anti-human VEGF receptor FLT-1 monoclonal antibody
7052705	Anti-angiogenic peptides
7064215	Indazole benzimidazole compounds
7405278	Chimeric human-type vascular endothelial cell growth factor
7393863	Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl- -carboxamide for the treatment and management of myelodysplastic syndromes
7381824	Quinoline derivatives
7374758	Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof
7374757	Modified chimeric polypeptides with improved pharmacokinetic properties
7368459	Heterocyclic compounds
7335774	Quinolinone derivatives
7335362	Methods of treating pre-eclampsia or eclampsia
7303694	Liquid crystals with reduced toxicity and applications thereof
7250395	Antagonist peptides to VEGF receptor Flt-1
7208500	Thienopyridine-phenylacetamides and their derivatives useful as new anti-angiogenic agents
7189740	Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
7138409	Heterocyclic compounds
7135171	Endothelial precursor cells for enhancing and restoring vascular function
7090834	Vascular endothelial cell growth factor variants and uses thereof
7070959	Modified chimeric polypeptides with improved pharmacokinetic properties
6413228	Devices, methods and systems for collecting material from a breast duct

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.